(Q46776598)

25 December 2017

title

Strict cysteamine dose regimen is required to prevent nocturnal cystine accumulation in cystinosis (English)

1 reference

25 December 2017

author

Henk J Blom

7

1 reference

25 December 2017

author name string

Elena N Levtchenko

1

1 reference

25 December 2017

Carin M van Dael

2

1 reference

25 December 2017

Addy C de Graaf-Hess

3

1 reference

25 December 2017

Martijn J G Wilmer

4

1 reference

25 December 2017

Lambertus P van den Heuvel

5

1 reference

25 December 2017

Leo A Monnens

6

1 reference

25 December 2017

publication date

27 October 2005

1 reference

25 December 2017

number of pages

4

1 reference

inferred from page(s)

published in

Pediatric Nephrology

1 reference

25 December 2017

volume

21

1 reference

25 December 2017

issue

1

1 reference

25 December 2017

page(s)

110-113

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1007/s00467-005-2052-0

exact match

0 references

cites work

Cystinosin, the protein defective in cystinosis, is a H(+)-driven lysosomal cystine transporter

1 reference

https://api.crossref.org/works/10.1007%2FS00467-005-2052-0

A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-005-2052-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-005-2052-0

Cystinosis. Intracellular cystine depletion by aminothiols in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-005-2052-0

First NIH/Office of Rare Diseases Conference on Cystinosis: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-005-2052-0

Swallowing dysfunction in 101 patients with nephropathic cystinosis: benefit of long-term cysteamine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-005-2052-0

A Comparison of the Effectiveness of Cysteamine and Phosphocysteamine in Elevating Plasma Cysteamine Concentration and Decreasing Leukocyte Free Cystine in Nephropathic Cystinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-005-2052-0

Steady-state pharmacokinetics and pharmacodynamics of cysteamine bitartrate in paediatric nephropathic cystinosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-005-2052-0

Comparison of cystine determination in mixed leukocytes vs polymorphonuclear leukocytes for diagnosis of cystinosis and monitoring of cysteamine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-005-2052-0

Treatment of cystinosis: simple in principle, difficult in practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-005-2052-0

Long-term follow-up of well-treated nephropathic cystinosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-005-2052-0

The evaluation and treatment of gastrointestinal disease in children with cystinosis receiving cysteamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-005-2052-0

New method for determining cystine in leukocytes and fibroblasts

21 January 2018

1 reference

12 December 2020

Detection and characterization of carrier-mediated cationic amino acid transport in lysosomes of normal and cystinotic human fibroblasts. Role in therapeutic cystine removal?

1 reference

12 December 2020

Improved renal function in children with cystinosis treated with cysteamine

1 reference

12 December 2020

An improved method for heterozygote detection of cystinosis, using polymorphonuclear leukocytes

1 reference

12 December 2020

10.1007/S00467-005-2052-0

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017